Prostate Cancer
Randomized trial of concomitant hypofractionated IMRT boost versus conventional fractionated IMRT boost for localized high-risk prostate cancer (pHART2-RCT).
November 22, 2023
Practical Use of Self-Adjusted Nitrous Oxide (SANO) During Transrectal Prostate Biopsy: A Double-Blind Randomized-Control Trial.
November 22, 2023
Is there a role for radical prostatectomy in the management of oligometastatic prostate cancer? A systematic review.
November 22, 2023
Prostate-Specific Membrane Antigen-Ligand Therapy: What the Radiologist Needs to Know.
November 21, 2023
The Molecular, Immunologic, and Clinicodemographic Landscape of MYC-Amplified Advanced Prostate Cancer.
November 21, 2023
Prostate Cancer Local Staging with Magnetic Resonance Imaging.
November 20, 2023
Phase 1b study of enzalutamide plus CC-115, a dual mTORC1/2 and DNA-PK inhibitor, in men with metastatic castration-resistant prostate cancer (mCRPC).
November 20, 2023
A Practical Guide to the Pearls and Pitfalls of PSMA PET Imaging.
November 20, 2023
Pfizer and Astellas' XTANDI® Approved by U.S. FDA in Earlier Prostate Cancer Treatment Setting
November 17, 2023
Prostate Cancer, Race, and Health Disparity: What We Know.
November 17, 2023
A US real-world study of treatment patterns and outcomes in localized or locally advanced prostate cancer patients.
November 17, 2023